Skip to content

Catalysing HIV/TB research: a meeting report

TB treatment guidelines need to change, systematic reviews show

d4T toxicity risk seven-fold higher when started with TB treatment

TB Alliance, Tibotec, form partnership to take forward new drug

TB treatment completion rates for HIV-positive UK patients: good but not quite on target [amended]

Double-dose lopinavir/ritonavir provides insufficient lopinavir exposure in children on rifampicin-based TB treatment

More treatment failure in people on TB treatment who start once daily nevirapine-based ART than efavirenz-based ART

Corticosteroid therapy improves outcomes in people with TB-IRIS in trial

TB research is research to save the lives of people with HIV